Resources & Archives
NEAVS
Calls for Immediate End to All Animal Toxicity Testing; Submits
Comments to Government Agencies
(Winter 2002) Scientists have concluded that
in vitro (non-animal) data could be used to set starting doses for
animal toxicity testing, reducing animal use by up to 30 percent
or more.
However, this is a very small accomplishment
when the goal is a 100% replacement of the use of all animals in
all such egregiously cruel testing. Their opinion was that non-animal
methods would require "further development" before they
could be used to totally replace animals.
In responding to these conclusions, NEAVS
President Dr. Theodora Capaldo and NEAVS
Scientific Advisor Dr. Cecilia Clemedson pointed out that there
is already ample evidence showing the benefits of using non-animal
alternatives in toxicity testing. A key example is the work of the
late internationally recognized Swedish toxicologist, Björn
Ekwall, MD, PhD. A key researcher on Ekwall’s team, Clemedson is
continuing his work.
Rather than supporting the half-measures of
reducing and refining animal use, NEAVS has called for an immediate
end to all animal toxicity testing and the incorporation of in vitro
non-animal models into all existing and planned toxicity testing
programs.
Dr. Ekwall’s model of human cell culture tests
has proven to be considerably more accurate in measuring and understanding
toxicity than are the animal tests currently used, NEAVS noted.
Collaboratively funded by NEAVS and other animal advocacy and scientific
organizations in the U.S. and Europe, the tests were evaluated in
a 10-year, multi-center study involving 29 laboratories in 15 countries.
Research such as Ekwall’s has shown that animal
testing, which animal advocates oppose as barbarously painful and
lethal to animals, is also flawed and misleading science. In fact,
the predictive accuracy of the Lethal Dose 50 (LD50) tests on rats
and mice has been estimated by Ekwall’s team to be only 60 and 65%
respectively, while the non-animal tests Ekwall developed, using
human cell line cultures, are 75% accurate in predicting human toxicity.
Using animals to assess the risk of acute
human chemical poisoning has serious shortcomings. For example,
animal testing can point out toxic symptoms, but cannot directly
point out toxic events such as specific organ damage.
With the addition of two types of in vitro
tests to Ekwall’s existing test battery, it also will be possible
to determine key kinetic events such as passage over biological
barriers and crucial organ-specific mechanisms, said Clemedson.
It is far better to wait for results from
these new cell tests and other validation studies before starting
any large-scale toxicity testing that would be based on individual
animal tests. Even if the proposed chemical testing were postponed
for a few years while waiting for the validation of further in vitro
tests, it is entirely likely that the testing still would be completed
earlier than if the chemical testing started immediately using standard
animal tests, according to Clemedson.
NEAVS’
comments to the Interagency Coordinating Committee on the Validation
of Alternative Toxicological Methods (ICCVAM) and the National Toxicology
Program Interagency Center for the Evaluation of Alternative Methods
(NICEATM) can be viewed online at http://iccvam.niehs.nih.gov/methods/invidocs/iv_comm.htm.
|